Evidence map›Paper›PMID 27042227›Full record

ArticleThoracic cancer2016

Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries.

Hongmei Zeng, Rongshou Zheng, Siwei Zhang, Tingting Zuo, Changfa Xia, Xiaonong Zou, Wanqing Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Thoracic cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 158 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongmei ZengNational Office for Cancer Prevention and Control Cancer Hospital, Chinese Academy of Medical Sciences Beijing China.
Rongshou ZhengNational Office for Cancer Prevention and Control Cancer Hospital, Chinese Academy of Medical Sciences Beijing China.
Siwei ZhangNational Office for Cancer Prevention and Control Cancer Hospital, Chinese Academy of Medical Sciences Beijing China.
Tingting ZuoNational Office for Cancer Prevention and Control Cancer Hospital, Chinese Academy of Medical Sciences Beijing China.
Changfa XiaNational Office for Cancer Prevention and Control Cancer Hospital, Chinese Academy of Medical Sciences Beijing China.
Xiaonong ZouNational Office for Cancer Prevention and Control Cancer Hospital, Chinese Academy of Medical Sciences Beijing China.
Wanqing ChenNational Office for Cancer Prevention and Control Cancer Hospital, Chinese Academy of Medical Sciences Beijing China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEsophageal cancer has been a common cancer in China for many years. Using the most recent data collected from the National Central Cancer Registry, we present estimates of the esophageal cancer burden in China in 2011.

methodsAge-specific incidence and mortality rates by gender and area for 18 age groups were calculated based on data from 177 qualified population-based cancer registries. The number of new cases of esophageal cancer and cancer deaths were computed by multiplying these rates by the 2011 population. Crude incidence and mortality rates of esophageal cancer were estimated.

resultsThe estimated number of new esophageal cancer cases and deaths were 291 238 and 218 957, respectively. The crude incidence and mortality rates for esophageal cancer were 21.62/100 000 and 16.25/100 000, respectively. The age-standardized incidence and mortality rates by world population were 15.83/100 000 and 11.62/100 000, respectively. Both the incidence and mortality rates of esophageal cancer were higher in rural areas than in urban areas, and in men than in women. The age-specific esophageal cancer incidence and mortality rates increased with age. In China, squamous cell cancer was the most common pathological type of the disease.

conclusionEsophageal cancer remains a major public health issue in China. Primary and secondary prevention are essential for disease control.

Indexed as

Chinaesophageal cancerincidencemortality

Identifiers

PMID27042227
PMCPMC4773307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.